OpenVSafe by OpenVAERS
Search V-safe

EWD-16138-41954

5 vaccinations 12 coded responses 57 check-ins 11 free-text entries 4 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
430 / OH
Registered
2021-02-17
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2593956 (opens in a new window) low 10 / 11 10 2 of 6 VAERS symptoms same dose (5) OH matches 2022-09-07 / 2023-02-18 / 2023-03-09
received the same day as the last call
case 309080

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-02-17
    Registered in v-safe
  2. 2021-02-17
    Dose 1 — Pfizer-BioNTech
  3. 2021-02-17
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-02-21
    Survey response — days 1–6 daily, dose 1
    MedDRA: Unevaluable event — Feeling: Fair · Fatigue or tiredness
    Free text: Chemo patient
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-02-23
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-02-24
    Health check-in — day 7, dose 1
    Feeling: Good · Abdominal pain
    Adult check-in
  11. 2021-03-03
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-10
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-10
    Health check-in — day 0, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  15. 2021-03-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  16. 2021-03-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  17. 2021-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling, Itching · Fever · Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  18. 2021-03-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling, Itching · None
    Adult check-in
  19. 2021-03-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Chemotherapy, Pre-existing disease — Feeling: Good · Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Last Chemo Feb 18, 2021
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-03-17
    Health check-in — day 7, dose 2
    Feeling: Good · Site: Itching · None
    Adult check-in
  21. 2021-03-24
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-03-31
    Survey response — day 21, dose 2
    MedDRA: Injection site pain, Injection site swelling — Feeling: Good
    Free text: Pain and swelling below injection site. No redness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-04-07
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-14
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-04-21
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-09
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-08-18
    Dose 3 — Pfizer-BioNTech
  28. 2021-08-18
    Survey response — day 0, dose 3
    MedDRA: Unevaluable event — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Chemotherapy patient thus todays symptoms
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  29. 2021-08-19
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  30. 2021-08-20
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  31. 2021-08-21
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  32. 2021-08-22
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  33. 2021-08-23
    Survey response — days 1–6 daily, dose 3
    MedDRA: Unevaluable event — Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Chemotherapy ptobably
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  34. 2021-08-24
    Survey response — days 1–6 daily, dose 3
    MedDRA: Unevaluable event — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Free text: Chemotherapy
    MedDRA releases: 2021-09,2024-11 · check-in free text available
  35. 2021-08-25
    Health check-in — day 7, dose 3
    Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  36. 2021-09-01
    Health check-in — day 14, dose 3
    Feeling: Fair
    Adult check-in
  37. 2021-09-08
    Health check-in — day 21, dose 3
    Feeling: Fair
    Adult check-in
  38. 2021-09-15
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  39. 2021-09-22
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  40. 2021-09-29
    Survey response — day 42, dose 3
    MedDRA: Blood pressure increased, Chemotherapy, Fatigue, Headache — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visit
    Free text: On oral Chemo Lynparza, and my BP has elevated to 190/107. Feeling very tired and headache. Starting addtl anti-hypertensive.
    MedDRA releases: 2024-11 · check-in free text available
  41. 2021-09-29
    Report sent to call center — day 42, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
  42. 2021-10-04
  43. 2021-11-17
    Health check-in — 3 months, dose 3
    Feeling: Fair
    Adult check-in
  44. 2022-02-16
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  45. 2022-04-11
    Dose 4 — Pfizer-BioNTech
  46. 2022-04-12
    Health check-in — days 1–6 daily, dose 4
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Adult check-in
  47. 2022-04-13
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  48. 2022-04-14
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · None · Be unable to do your normal daily activities
    Adult check-in
  49. 2022-04-15
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · None
    Adult check-in
  50. 2022-04-16
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  51. 2022-04-17
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  52. 2022-04-18
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  53. 2022-04-25
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  54. 2022-05-02
    Survey response — day 21, dose 4
    MedDRA: Unevaluable event — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Chemotherapy
    MedDRA releases: 2024-11 · check-in free text available
  55. 2022-05-09
    Health check-in — day 28, dose 4
    Feeling: Fair
    Adult check-in
  56. 2022-05-16
    Health check-in — day 35, dose 4
    Feeling: Fair
    Adult check-in
  57. 2022-05-23
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  58. 2022-07-11
    Health check-in — 3 months, dose 4
    Feeling: Fair
    Adult check-in
  59. 2022-09-07
    Dose 5 — Moderna
  60. 2022-10-01
    Survey response — day 21, dose 5
    MedDRA: Adverse drug reaction, Chemotherapy, Ovarian cancer — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit
    Free text: Pulmonary Embolism related to Ovarian Cancer and Chemo
    MedDRA releases: 2024-11 · check-in free text available
  61. 2022-10-01
    Report sent to call center — day 21, dose 5
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Emergency room or emergency department visit · 1 call case(s)
  62. 2022-10-03
    Call successful
    Participant prefers to complete VAERS report online
  63. 2022-10-03
    Call successful
    Participant prefers to complete VAERS report online
  64. 2022-10-05
    Health check-in — day 28, dose 5
    Feeling: Fair
    Adult check-in
  65. 2022-10-13
    Survey response — day 35, dose 5
    MedDRA: Fatigue, Headache, Myalgia, Nausea, Oropharyngeal pain — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Sore throat, muscle pain, headache, nausea and fatigue lasting 2 weeks
    MedDRA releases: 2024-11 · check-in free text available
  66. 2022-10-19
    Health check-in — day 42, dose 5
    Feeling: Fair
    Adult check-in
  67. 2022-12-07
    Survey response — 3 months, dose 5
    MedDRA: Office visit, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional
    Free text: Symptoms: Reactivation of Epstein-Barr Virus about 3 weeks after Bivalent booster. · Healthcare visit (other): Saw primary care MD
    MedDRA releases: 2024-11 · check-in free text available
  68. 2022-12-07
    Report sent to call center — 3 months, dose 5
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    1 call case(s)
  69. 2022-12-08
  70. 2023-03-08
    Survey response — 6 months, dose 5
    MedDRA: Eczema, Office visit — Feeling: Fair · Get care from a doctor or other healthcare professional
    MedDRA releases: 2024-11
  71. 2023-03-08
    Report sent to call center — 6 months, dose 5
    Get care from a doctor or other healthcare professional
    1 call case(s)
  72. 2023-03-09
    Call successful
    Reported to VAERS during previous contact from GDIT

Vaccinations

DoseDateManufacturerCo-administered
12021-02-17Pfizer-BioNTech
22021-03-10Pfizer-BioNTech
32021-08-18Pfizer-BioNTech No
42022-04-11Pfizer-BioNTech No
52022-09-07Moderna No

Call center

4 call center cases

4 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 4 — days 1–6 daily, dose 1

2021-02-21

Systemic reaction (other): Chemo patient

Release 5 — days 1–6 daily, dose 2

2021-03-16

Systemic reaction (other): Last Chemo Feb 18, 2021

Release 6 — day 21, dose 2

2021-03-31

Symptoms: Pain and swelling below injection site. No redness

Release 9 — day 0, dose 3

2021-08-18

Systemic reaction (other): Chemotherapy patient thus todays symptoms

Release 9 — days 1–6 daily, dose 3

2021-08-23

Systemic reaction (other): Chemotherapy ptobably

2021-08-24

Systemic reaction (other): Chemotherapy

Release 9 — day 42, dose 3

2021-09-29

Symptoms: On oral Chemo Lynparza, and my BP has elevated to 190/107. Feeling very tired and headache. Starting addtl anti-hypertensive.

Release 11 — day 21, dose 4

2022-05-02

Symptoms: Chemotherapy

Release 12 — day 21, dose 5

2022-10-01

Symptoms: Pulmonary Embolism related to Ovarian Cancer and Chemo

Release 12 — day 35, dose 5

2022-10-13

Symptoms: Sore throat, muscle pain, headache, nausea and fatigue lasting 2 weeks

Release 12 — 3 months, dose 5

2022-12-07

Symptoms: Reactivation of Epstein-Barr Virus about 3 weeks after Bivalent booster.
Healthcare visit (other): Saw primary care MD

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOOffice visit · · ✓
SDAdverse drug reaction · · ✓
SDBlood pressure increased · · ✓
SDChemotherapy · · ✓
SDEczema · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDInjection site pain ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDMyalgia · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDOvarian cancer · · ✓
SDPre-existing disease · · ✓
SDUnevaluable event · · ✓
SROChemotherapy ✓ ✓ ✓
SROPre-existing disease ✓ ✓ ✓
SROUnevaluable event ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release